Cost-effectiveness of abiraterone treatment in patients with castration-resistant prostate cancer who previously received docetaxel therapy

<p><strong>Background.</strong> Therapy for metastatic castration-resistant prostate cancer (CRPC) is a serious problem that requires significant public health care expenditures.</p><p><strong>Objective</strong>: to evaluate the cost-effectiveness of abirate...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: A. V. Rudakova, D. O. Meshkov, S. V. Mishugin
Formáid: Artigo
Teanga:Russo
Foilsithe: ABV-press 2014-11-01
Sraith:Onkourologiâ
Ábhair:
castration-resistant prostate cancer
chemotherapy
docetaxel
abiraterone
survival
cost effectiveness
Rochtain Ar Líne:http://oncourology.abvpress.ru/index.php/oncur/article/view/383
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla